{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Inherited+Hematological+Diseases&page=10", "query": { "condition": "Inherited Hematological Diseases", "page": 10 }, "page_size": 10 }, "pagination": { "page": 10, "page_size": 10, "total_count": 2013, "total_pages": 202, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Inherited+Hematological+Diseases&page=11&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Inherited+Hematological+Diseases&page=9&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-14T21:33:57.225Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05730205", "title": "Effects of the Contraceptive Implant in Women With Sickle Cell Disease", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Sickle Cell Disease" ], "interventions": [ { "name": "Nexplanon 68 MG Drug Implant", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "FEMALE", "summary": "18 Years to 45 Years · Female only" }, "enrollment_count": 22, "start_date": "2023-08-02", "completion_date": "2027-03", "has_results": false, "last_update_posted_date": "2026-06-12", "last_synced_at": "2026-10-14T21:33:57.225Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05730205" }, { "nct_id": "NCT00084305", "title": "Analysis of Specimens From Individuals With Pulmonary Fibrosis", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pulmonary Fibrosis", "Healthy Volunteers", "Hermansky-Pudlak Syndrome (HPS)" ], "interventions": [], "intervention_types": [], "sponsor": "National Human Genome Research Institute (NHGRI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "115 Years", "sex": "ALL", "summary": "18 Years to 115 Years" }, "enrollment_count": 315, "start_date": "2004-06-09", "completion_date": null, "has_results": false, "last_update_posted_date": "2026-10-13", "last_synced_at": "2026-10-14T21:33:57.225Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00084305" }, { "nct_id": "NCT04675645", "title": "Adherence to HU and HRQOL in Patients With Sickle Cell Disease: An Intervention Study Using HU-Go App", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Sickle Cell Disease", "Sickle B+ Thalassemia", "Sickle Beta Zero Thalassemia", "Sickle Cell Hemoglobin C" ], "interventions": [ { "name": "HU-Go app", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Ann & Robert H Lurie Children's Hospital of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "25 Years", "sex": "ALL", "summary": "12 Years to 25 Years" }, "enrollment_count": 33, "start_date": "2018-05-15", "completion_date": "2020-07-11", "has_results": false, "last_update_posted_date": "2021-07-29", "last_synced_at": "2026-10-14T21:33:57.225Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT04675645" }, { "nct_id": "NCT06754852", "title": "A Study Assessing HMB-002 in Participants With Von Willebrand Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Von Willebrand Disease (VWD)", "Von Willebrand Disease (VWD), Type 1", "Von Willebrand Disease (VWD), Type 2", "Von Willebrand Disease (VWD), Type 3" ], "interventions": [ { "name": "HMB-002 (Part A)", "type": "DRUG" }, { "name": "HMB-002 (Part B)", "type": "DRUG" }, { "name": "HMB-002 with Concomitant Factor Concentrate (Part C) (Not Applicable in US)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hemab ApS", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "69 Years", "sex": "ALL", "summary": "16 Years to 69 Years" }, "enrollment_count": 108, "start_date": "2025-02-06", "completion_date": "2027-07", "has_results": false, "last_update_posted_date": "2026-06-30", "last_synced_at": "2026-10-14T21:33:57.225Z", "location_count": 13, "location_summary": "Phoenix, Arizona • Little Rock, Arkansas • Los Angeles, California + 10 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06754852" }, { "nct_id": "NCT01796678", "title": "Arginine Therapy in Sickle Cell Disease-VOC Clinical Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Vaso-occlusive Pain Episodes" ], "interventions": [ { "name": "Arginine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "UCSF Benioff Children's Hospital Oakland", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "3 Years to 21 Years" }, "enrollment_count": 56, "start_date": "2000-09", "completion_date": "2007-06", "has_results": false, "last_update_posted_date": "2013-07-31", "last_synced_at": "2026-10-14T21:33:57.225Z", "location_count": 1, "location_summary": "Oakland, California", "locations": [ { "city": "Oakland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01796678" }, { "nct_id": "NCT07601425", "title": "Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Hereditary Hemorrhagic Telangiectasia (HHT)", "Osler Weber Rendu Disease" ], "interventions": [ { "name": "ATV-1601", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Atavistik Bio, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2026-07-27", "completion_date": "2030-03", "has_results": false, "last_update_posted_date": "2026-10-05", "last_synced_at": "2026-10-14T21:33:57.225Z", "location_count": 6, "location_summary": "Phoenix, Arizona • Augusta, Georgia • Indianapolis, Indiana + 3 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Augusta", "state": "Georgia" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT07601425" }, { "nct_id": "NCT05283148", "title": "Sickle Cell Disease (SCD) Bone Pain Study", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Sickle Cell Disease", "Sickle Cell Anemia", "Low Bone Density", "Osteoporosis", "Osteopenia", "Vertebral Fracture", "Vertebral Compression", "Osteonecrosis", "Ischemic Necrosis", "Avascular Necrosis" ], "interventions": [ { "name": "Dual-energy X-ray absorptiometry", "type": "OTHER" }, { "name": "Vertebral fracture analysis", "type": "OTHER" }, { "name": "Adult Sickle Cell Quality of Life Measurement System pain impact questionnaire", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of California, Davis", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 53, "start_date": "2022-11-03", "completion_date": "2027-12-31", "has_results": true, "last_update_posted_date": "2026-09-23", "last_synced_at": "2026-10-14T21:33:57.225Z", "location_count": 1, "location_summary": "Sacramento, California", "locations": [ { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05283148" }, { "nct_id": "NCT01869114", "title": "Sirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive Chemotherapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities", "Adult Acute Myeloid Leukemia With Del(5q)", "Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)", "Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)", "Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)", "Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)", "de Novo Myelodysplastic Syndromes", "Myelodysplastic Syndrome With Isolated Del(5q)", "Previously Treated Myelodysplastic Syndromes", "Recurrent Adult Acute Myeloid Leukemia" ], "interventions": [ { "name": "Sirolimus", "type": "DRUG" }, { "name": "Azacitidine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 57, "start_date": "2013-07-08", "completion_date": "2024-01-03", "has_results": true, "last_update_posted_date": "2025-12-10", "last_synced_at": "2026-10-14T21:33:57.225Z", "location_count": 5, "location_summary": "Sewell, New Jersey • Abington, Pennsylvania • Philadelphia, Pennsylvania", "locations": [ { "city": "Sewell", "state": "New Jersey" }, { "city": "Abington", "state": "Pennsylvania" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01869114" }, { "nct_id": "NCT00499785", "title": "Physical and Mental Assessment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cognitive/Functional Effects", "Depression", "Leukemia" ], "interventions": [], "intervention_types": [], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "60 Years to 120 Years" }, "enrollment_count": 11, "start_date": "2007-06", "completion_date": "2012-01", "has_results": false, "last_update_posted_date": "2017-05-30", "last_synced_at": "2026-10-14T21:33:57.225Z", "location_count": 1, "location_summary": "Winston-Salem, North Carolina", "locations": [ { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00499785" }, { "nct_id": "NCT07019155", "title": "Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Germline Mutation", "Myelodysplastic Syndromes", "Acute Myeloid Leukemia" ], "interventions": [], "intervention_types": [], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Month", "maximum_age": "120 Years", "sex": "ALL", "summary": "1 Month to 120 Years" }, "enrollment_count": 510, "start_date": "2025-07-24", "completion_date": "2035-06-15", "has_results": false, "last_update_posted_date": "2026-07-06", "last_synced_at": "2026-10-14T21:33:57.225Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT07019155" } ] }